论文部分内容阅读
目的分析血液透析滤过对尿毒症难治性高血压临床疗效。方法通过对江苏省如皋市人民医院血透室42例难治性高血压,采用血液透析(HD)和血液透析滤过(HDF)两种不同的透析方法治疗难治性高血压,监测两组治疗前和治疗3个月后平均动脉压和血肌酐(Scr)、尿素氮(BUN)、血浆肾素活性(Pra)、血管紧张素Ⅱ(AngⅡ)、醛固酮(ALD)的变化,观察并分析血液透析滤过两种疗效。结果血液透析滤过组治疗后血压、Pra、AngⅡ、ALD均较治疗前明显降低,血液透析组治疗前后平均动脉压、Pra、AngⅡ、ALD未见明显下降。结论血液透析滤过对尿毒症难治性高血压疗效优于常规血透。
Objective To analyze the clinical effect of hemodiafiltration on patients with refractory hypertension of uremia. Methods Forty-two patients with refractory hypertension in the hemodialysis room of Rugao People’s Hospital of Jiangsu Province were treated with two different hemodialysis (HD) and hemodiafiltration (HDF) dialysis methods to treat refractory hypertension. Two groups Mean arterial pressure and blood creatinine (Scr), blood urea nitrogen (BUN), plasma renin activity (Pra), angiotensin Ⅱ (Ang Ⅱ) and aldosterone (ALD) were measured before and 3 months after treatment. Hemodiafiltration two effects. Results Blood pressure, Pra, AngⅡ and ALD in hemodiafiltration group were significantly lower than those before treatment. Mean arterial pressure, Pra, AngⅡ and ALD in hemodialysis group before and after treatment were not significantly decreased. Conclusion Hemodiafiltration is superior to conventional hemodialysis in refractory hypertension of uremia.